| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
27
H
30
N
2
O
2
. Powder Diffraction , 1-6. 10.1017/s0885715625100869. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
24
H
28
N
3
O
4
Cl(H
2
O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of flumethasone, C22H28F2O5. Powder Diffraction , 1-6. 10.1017/s0885715625000120. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of diroximel fumarate, C11H13NO6. Powder Diffraction , 1-6. 10.1017/s0885715625000119. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of etrasimod, C26H26F3NO3. Powder Diffraction , 1-6. 10.1017/s0885715625000107. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of racemic benserazide hydrochloride Form I, C10H16N3O5Cl. Powder Diffraction , 1-7. 10.1017/s0885715624000496. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of gepirone, C19H29N5O2. Powder Diffraction , 1-6. 10.1017/s0885715624000514. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas (2025). Crystal structure of sparsentan, C32H40N4O5S. Powder Diffraction 40(2) , 157-161. 10.1017/s0885715625000132. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A. (2026). Interesting hurdles in the solution of pharmaceutical crystal structures using powder diffraction data. Acta Crystallographica Section E Crystallographic Communications 82(10) . 10.1107/s2056989026009382. |
BXDS-WLE |
Peer-Reviewed Article |
Materials |
| Kaban, I.; Jóvári, P.; Escher, B.; Tran, D.T.; Svensson, G. et al. (2015). Atomic structure and formation of CuZrAl bulk metallic glasses and composites. Acta Materialia 100, 369-376. 10.1016/j.actamat.2015.08.060. |
HXMA, SGM |
Peer-Reviewed Article |
Materials |
| Kaasalainen, Martti; Zhang, Ran; Vashisth, Priya; Birjandi, Anahid Ahmadi; S’Ari, Mark et al. (2024). Lithiated porous silicon nanowires stimulate periodontal regeneration. Nature Communications 15(1) . 10.1038/s41467-023-44581-5. |
VLS-PGM |
Peer-Reviewed Article |
Health |
| J·赛瓦内苏阿雷斯; J·阿尼多福尔盖拉; P·A·吉布林; P·E·拜利斯; J·弗兰松 et al. (2021). Method for quantifying LIF and uses thereof. Patent Number: CN112654395A. |
|
Patent |
|
| J·塞奥内苏亚雷斯; J·阿尼多富尔盖拉; J·弗兰森; R·M·哈勒特; M·帕斯夸尔加西亚 et al. (2021). Combination of LIF inhibitors and PD-1 axis inhibitors for the treatment of cancer. Patent Number: CN112585164A. |
|
Patent |
|